Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.
Press releases published on July 8, 2025
Logan Golema Joins Alpha Liquid Terminal as Advisor to Drive AI and Blockchain Innovation in Research and Trading
GlobeNewswire
·
July 8, 2025
New York, NY, July 08, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid Terminal (ALTx), a next-generation modular trading platform powered by AI agents, proudly announces the appointment of Logan Golema as an advisor. A trailblazer in the convergence of artificial …
Shoals Technologies Group Expands into South American Market with Alcones Solar Project in Chile with CJR Renewables
GlobeNewswire
·
July 8, 2025
PORTLAND, Tenn., July 08, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced the execution of a contract with CJR …
Coralogix Signs Strategic Collaboration Agreement with AWS to Advance AI-Powered Observability and Security
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Coralogix, a leading full-stack observability platform provider, today announced a strategic collaboration agreement (SCA) with Amazon Web Services (AWS). Through this collaboration, Coralogix and AWS will create …
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
GlobeNewswire
·
July 8, 2025
MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has …
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
GlobeNewswire
·
July 8, 2025
DURHAM, N.C., July 08, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that Symvess has been …
RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics
GlobeNewswire
·
July 8, 2025
SUNNYVALE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced its partnership with Kinova, a global leader in professional and medical robotics. This collaboration …
Certara Announces Expansion of Clinical Technology Collaboration with Merck
GlobeNewswire
·
July 8, 2025
RADNOR, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, that expands Merck’s use …
Vaxart Announces Trading on OTCQX Best Market
GlobeNewswire
·
July 8, 2025
SOUTH SAN FRANCISCO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Treatment.com AI Announces Momentum Following Acquisition of Rocket Doctor, Highlighting Growth, Innovation, and National Recognition
GlobeNewswire
·
July 8, 2025
Treatment.com AI completed the acquisition of Rocket Doctor, aligning AI-powered clinical intelligence with a proven virtual care delivery platform. Rocket Doctor patient volume grew 112% in Alberta year-over-year, with over 36,000 patients seen in 2024 …
Enterprises Enhance Privacy, Security and Control with Rackspace Technology’s OpenStack Business Private Cloud
GlobeNewswire
·
July 8, 2025
SAN ANTONIO, July 08, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the launch of Rackspace OpenStack Business, a new, open source, dedicated private cloud for …
Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP
GlobeNewswire
·
July 8, 2025
Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (“Beacon Therapeutics” or ”the Company”), a leading clinical-stage biotechnology company with a mission to save and restore …
Cloudbrink Named a Leader and Fast Mover in the GigaOm Radar for Zero-Trust Network Access (ZTNA)
GlobeNewswire
·
July 8, 2025
SUNNYVALE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Cloudbrink, a leader in high-performance secure connectivity, today announced that respected industry analyst firm GigaOm has positioned Cloudbrink Personal SASE as a Leader and Fast Mover in the …
ZenaTech Poised to Benefit from Historic US Defense Spending─$33 Billion for Drone and Autonomy Investments in ‘One Big Beautiful Bill’
GlobeNewswire
·
July 8, 2025
VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and …
Nano Labs Announces Strategic Partnership with Orbiter Finance to Launch Compliant Stablecoin Cross-Chain Solution NBNB.io
GlobeNewswire
·
July 8, 2025
HONG KONG, July 08, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced a strategic partnership with Layer 2 cross-chain bridge …
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
GlobeNewswire
·
July 8, 2025
MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has …
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies
GlobeNewswire
·
July 8, 2025
Drug-drug interaction (“DDI”) clinical studies help identify the potential for side effects, or in some cases, reduced therapeutic efficacy, that may be caused by interactions between different drugs. The market leading epidermal growth factor receptor (“ …
Genius Group increases Bitcoin Treasury 23% to 148 Bitcoin, achieves 113% BTC Yield.
GlobeNewswire
·
July 8, 2025
SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on July 7, 2025 it purchased 28 Bitcoin, increasing its …
Marquess School Global Ltd Launches Flagship Product Marquess Core AI, Ushering in a New Era of Intelligent Wealth Management
GlobeNewswire
·
July 8, 2025
Denver, USA, July 08, 2025 (GLOBE NEWSWIRE) -- In a bold move that redefines the landscape of intelligent wealth management, Marquess School Global Ltd today announced the launch of its flagship AI-powered investment system, Marquess Core AI. This …
Lucinity Achieves Microsoft Certified Software for Financial AI
GlobeNewswire
·
July 8, 2025
REYKJAVIK, Iceland, July 08, 2025 (GLOBE NEWSWIRE) -- Lucinity, a leading provider of anti-financial crime software, announced today that its platform is now officially recognized as Microsoft Certified Software for Financial AI. This certification …
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
GlobeNewswire
·
July 8, 2025
HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …